| P50 | author | Christopher Logg | Q57412367 |
| P2093 | author name string | Noriyuki Kasahara | |
| | Douglas J Jolly | |
| | Harry E Gruber | |
| | Joan M Robbins | |
| P2860 | cites work | Cell-to-cell transmission of retroviruses: Innate immunity and interferon-induced restriction factors | Q24604018 |
| | Cancer despite immunosurveillance: immunoselection and immunosubversion | Q28263865 |
| | Adaptation of chimeric retroviruses in vitro and in vivo: isolation of avian retroviral vectors with extended host range | Q33851610 |
| | A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors | Q33949381 |
| | Integration of murine leukemia virus DNA depends on mitosis | Q34051046 |
| | Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing. | Q34124490 |
| | Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene | Q34124630 |
| | Recent clinical experience with oncolytic viruses. | Q34198918 |
| | Tissue-specific transcriptional targeting of a replication-competent retroviral vector | Q34350999 |
| | Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma | Q34463785 |
| | Cancer gene therapy: fringe or cutting edge? | Q34572090 |
| | History of oncolytic viruses: genesis to genetic engineering | Q34575505 |
| | The emerging fields of suicide gene therapy and virotherapy. | Q34583921 |
| | Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection | Q35000208 |
| | Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus | Q35861853 |
| | In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies | Q35942568 |
| | Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors | Q36386486 |
| | Gene therapy for glioblastoma. | Q36481964 |
| | Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance | Q36752974 |
| | CNS metastasis: an old problem in a new guise | Q36760992 |
| | Host factors involved in resistance to retroviral infection | Q37199338 |
| | Impaired interferon signaling is a common immune defect in human cancer | Q37211332 |
| | Searching for a cure: gene therapy for glioblastoma | Q37245716 |
| | The polarization of immune cells in the tumour environment by TGFbeta | Q37454364 |
| | Replication-competent Moloney murine leukemia virus carrying a bacterial suppressor tRNA gene: selective cloning of proviral and flanking host sequences | Q37678275 |
| | The interface between the innate interferon response and expression of host retroviral restriction factors | Q37772341 |
| | Oncolytic virotherapy reaches adolescence | Q37782043 |
| | Clinical development directions in oncolytic viral therapy | Q37857659 |
| | Clinical development of experimental virus-mediated gene therapy for malignant glioma. | Q37894782 |
| | Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary | Q39603791 |
| | A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent | Q39647264 |
| | Optimization of enzyme-substrate pairing for bioluminescence imaging of gene transfer using Renilla and Gaussia luciferases | Q39696296 |
| | Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus | Q40037960 |
| | Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors | Q40144043 |
| | Tumor-selective gene expression in a hepatic metastasis model after locoregional delivery of a replication-competent retrovirus vector | Q40200936 |
| | Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model | Q40278329 |
| | A Pitfall of the 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethonyphenol)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay due to evaporation in wells on the edge of a 96 well plate | Q40387424 |
| | Mechanisms of retroviral mutation | Q41125660 |
| | The maturation of human gene therapy | Q41256692 |
| | Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors | Q41494111 |
| | Replicative retroviral vectors for cancer gene therapy | Q42807227 |
| | Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors | Q44340113 |
| | Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma | Q44505735 |
| | Immune response to Moloney-murine leukemia virus-induced antigens in bone marrow. | Q44574317 |
| | Retrovirus-mediated gene transfer to tumors: utilizing the replicative power of viruses to achieve highly efficient tumor transduction in vivo | Q44852618 |
| | Construction and recovery of viable retroviral genomes carrying a bacterial suppressor transfer RNA gene | Q44959582 |
| | Effects of Adoptive Immune Transfers on Murine Leukemia Virus-Infection of Rats | Q45787552 |
| | Naturally occurring humoral immunity to endogenous xenotropic and amphotropic type-C virus in the mouse | Q45801402 |
| | Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts | Q45857498 |
| | Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model | Q45868598 |
| | Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors | Q45869903 |
| | Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts. | Q50701758 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 199-228 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Methods in Enzymology | Q2076903 |
| P1476 | title | Retroviral replicating vectors in cancer | |
| P478 | volume | 507 | |